Recruiting Obinutuzumab in Treatment of Fibrillary Glomerulonephritis NCT06295770 Conditions Fibrillary Glomerulonephritis Locations Mayo Clinic — Rochester, Minnesota, United States View Trial Details
Recruiting National Registry of Rare Kidney Diseases NCT06065852 Conditions AH Amyloidosis, AHL Amyloidosis, AL Amyloidosis, +207 more Locations Zoe Plummer — Bristol, South West, United Kingdom View Trial Details
Completed Two Anti-CD20 Regimens for Fibrillary Glomerulonephritis NCT06680349 Conditions Fibrillary Glomerulonephritis Locations San Giovanni Bosco Hub Hospital — Torino, Italy View Trial Details
Completed Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis NCT02197767 Conditions Fibrillary Glomerulonephritis Locations Mayo Clinic in Rochester — Rochester, Minnesota, United States View Trial Details
